ERBB2 and triple-negative breast carcinoma: Human triple-negative breast cancer (TNBC), which accounts for approximately 10–20% of all breast tumors, refers to forms that do not express estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [2].